Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy

This publication has 33 references indexed in Scilit:

• Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes
  Life Sciences, 2007
• Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway
  Experimental & Molecular Medicine, 2006
• βig-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through αvβ5 integrin
  Experimental & Molecular Medicine, 2006
• Serum Levels of Advanced Glycation End Products Are Associated with In-Stent Restenosis in Diabetic Patients
  Yonsei Medical Journal, 2005
• Neointimal Formation After Endovascular Arterial Injury Is Markedly Attenuated in db/db Mice
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
• Advanced glycation end products activate Smad signaling via TGF‐β‐dependent and ‐independent mechanisms: implications for diabetic renal and vascular disease
  The FASEB Journal, 2003
• Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways
  Journal of Biological Chemistry, 1999
• ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING
  Annual Review of Medicine, 1995
• Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
  New England Journal of Medicine, 1988
• Diabetes and cardiovascular disease. The Framingham study
  JAMA, 1979